JP2022550390A5 - - Google Patents

Info

Publication number
JP2022550390A5
JP2022550390A5 JP2022519662A JP2022519662A JP2022550390A5 JP 2022550390 A5 JP2022550390 A5 JP 2022550390A5 JP 2022519662 A JP2022519662 A JP 2022519662A JP 2022519662 A JP2022519662 A JP 2022519662A JP 2022550390 A5 JP2022550390 A5 JP 2022550390A5
Authority
JP
Japan
Prior art keywords
protein binder
irhom2
human
binder according
sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022519662A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022550390A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2020/077346 external-priority patent/WO2021064009A1/en
Publication of JP2022550390A publication Critical patent/JP2022550390A/ja
Publication of JP2022550390A5 publication Critical patent/JP2022550390A5/ja
Priority to JP2025131956A priority Critical patent/JP2025179064A/ja
Pending legal-status Critical Current

Links

JP2022519662A 2019-09-30 2020-09-30 iRhom2エピトープに結合するタンパク質バインダー Pending JP2022550390A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025131956A JP2025179064A (ja) 2019-09-30 2025-08-07 iRhom2エピトープに結合するタンパク質バインダー

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP19200589 2019-09-30
EP19200589.0 2019-09-30
PCT/EP2020/077346 WO2021064009A1 (en) 2019-09-30 2020-09-30 Protein binders to irhom2 epitopes

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025131956A Division JP2025179064A (ja) 2019-09-30 2025-08-07 iRhom2エピトープに結合するタンパク質バインダー

Publications (2)

Publication Number Publication Date
JP2022550390A JP2022550390A (ja) 2022-12-01
JP2022550390A5 true JP2022550390A5 (https=) 2023-10-11

Family

ID=68104520

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022519662A Pending JP2022550390A (ja) 2019-09-30 2020-09-30 iRhom2エピトープに結合するタンパク質バインダー
JP2025131956A Pending JP2025179064A (ja) 2019-09-30 2025-08-07 iRhom2エピトープに結合するタンパク質バインダー

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025131956A Pending JP2025179064A (ja) 2019-09-30 2025-08-07 iRhom2エピトープに結合するタンパク質バインダー

Country Status (7)

Country Link
US (1) US20240287172A1 (https=)
EP (1) EP4037699A1 (https=)
JP (2) JP2022550390A (https=)
CN (1) CN115151270A (https=)
AU (1) AU2020360849A1 (https=)
CA (1) CA3151450A1 (https=)
WO (1) WO2021064009A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2024510415A (ja) 2021-03-01 2024-03-07 スキロム ゲゼルシャフト ミット ベシュレンクテル ハフツング iRhom2に対するヒト化抗体
US20240174744A1 (en) * 2021-03-29 2024-05-30 Scirhom Gmbh Methods of treatment using protein binders to irhom2 epitopes

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US6548640B1 (en) 1986-03-27 2003-04-15 Btg International Limited Altered antibodies
US5223409A (en) 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
EP0368684B2 (en) 1988-11-11 2004-09-29 Medical Research Council Cloning immunoglobulin variable domain sequences.
US5859205A (en) 1989-12-21 1999-01-12 Celltech Limited Humanised antibodies
ES2176484T3 (es) 1995-08-18 2002-12-01 Morphosys Ag Bancos de proteinas/(poli)peptidos.
AR038568A1 (es) 2002-02-20 2005-01-19 Hoffmann La Roche Anticuerpos anti-a beta y su uso
WO2003073843A2 (en) 2002-03-05 2003-09-12 Artemis Pharmaceuticals Gmbh Inbred embryonic stem-cell derived mice
GB0624500D0 (en) * 2006-12-07 2007-01-17 Istituto Superiore Di Sanito A novel passive vaccine for candida infections
WO2014043223A1 (en) * 2012-09-11 2014-03-20 Hospital For Special Surgery Irhom2 inhibition for the treatment of complement mediated disorders
KR20150056788A (ko) 2012-09-19 2015-05-27 애브비 바이오테라퓨틱스 인크. 면역원성이 감소된 항체의 동정 방법
US10024844B2 (en) * 2012-12-20 2018-07-17 Hospital For Special Surgery Identification of an inhibitor of iRhom1 or an inhibitor of iRhom2
CN106471130A (zh) * 2014-05-09 2017-03-01 杰克逊实验室 鉴定改变iRhom多肽活性的化合物的方法及其用途
CA2874083C (en) * 2014-12-05 2024-01-02 Universite Laval Tdp-43-binding polypeptides useful for the treatment of neurodegenerative diseases
CN109045056A (zh) * 2018-07-04 2018-12-21 重庆第二师范学院 多药载药靶向纳米颗粒及其制备方法和应用
CN113993534A (zh) * 2019-04-09 2022-01-28 特殊外科医院 针对iRhom2的蛋白结合物

Similar Documents

Publication Publication Date Title
HRP20191999T1 (hr) Monoklonska protutijela anti-faktora xi i postupci njihove uporabe
Fischer et al. Combined inhibition of tumor necrosis factor α and interleukin‐17 as a therapeutic opportunity in rheumatoid arthritis: Development and characterization of a novel bispecific antibody
JP2024167313A5 (https=)
JP2022191301A5 (https=)
JP2015514110A5 (https=)
JP2021532170A5 (https=)
JP2017113019A5 (https=)
HRP20220811T1 (hr) Agonistička sredstva za vezanje tnf receptora
JP2021529557A5 (https=)
JP2021526022A5 (https=)
JP2009518005A5 (https=)
JP2019505527A5 (https=)
HRP20231196T1 (hr) Nova protutijela koja se specifično vežu na epitope zika virusa i njihova upotreba
JP2015503909A5 (https=)
JP2004510752A5 (https=)
JP2019521647A5 (https=)
JP2009539348A5 (https=)
JP2023545183A5 (https=)
JP2018521691A5 (https=)
AU2011329647A1 (en) Neutralizing anti-CCL20 antibodies
JP2019511911A5 (https=)
CN105358175B (zh) 用于治疗硬皮病的抗ccl2和抗loxl2组合疗法
JP2016519650A5 (https=)
CN102027015A (zh) 抗cxcr4抗体
JP2008525033A5 (https=)